<
Back to Previous Page
Invivodata And PHT Settle Patent Lawsuits
PITTSBURGH and CHARLESTOWN, Mass. — invivodata, inc. and PHT Corporation, leading providers of electronic patient reported outcome (ePRO) solutions used in clinical research, announced that a settlement has been reached in PHT’s patent infringement lawsuit against invivodata filed on Jan. 28, 2004. Although the terms of the settlement remain confidential, PHT has granted invivodata a fully paid-up worldwide license for its patents. Today’s agreement also settles the patent infringement lawsuit that invivodata filed against PHT on June 21, 2005 , and provides PHT with a fully paid-up worldwide license for invivodata’s patent. Both of the lawsuits have now been dropped.
“We are pleased that we were able to amicably reach an agreement with invivodata and cross-license each other’s patents,” said Phil Lee, PHT president and CEO. “This settlement is good for the ePRO industry and for adoption, as it brings stability to the market and enables both companies to focus their resources on meeting the needs of its clients.”
“We are very pleased with the settlement and are looking forward to growing both our business and the ePRO market in the coming year,” said Doug Engfer, founder, president and CEO of invivodata. “This is good news for both companies and, more importantly, for customers who require high-quality data from the subjects in their clinical trials.”
Call Our Toll Free: (888) 275-2757 or Contact Us Online For a No-Obligation Consultation |
